KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to 6.63%.

  • Repligen's EBITDA Margin rose 7100.0% to 6.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.56%, marking a year-over-year increase of 44500.0%. This contributed to the annual value of 6.34% for FY2024, which is 114300.0% down from last year.
  • Latest data reveals that Repligen reported EBITDA Margin of 6.63% as of Q3 2025, which was up 7100.0% from 33.44% recorded in Q2 2025.
  • Repligen's 5-year EBITDA Margin high stood at 37.26% for Q4 2022, and its period low was 30.9% during Q4 2024.
  • Its 5-year average for EBITDA Margin is 10.25%, with a median of 11.08% in 2022.
  • Per our database at Business Quant, Repligen's EBITDA Margin crashed by -438000bps in 2023 and then surged by 307900bps in 2025.
  • Quarter analysis of 5 years shows Repligen's EBITDA Margin stood at 11.87% in 2021, then surged by 214bps to 37.26% in 2022, then crashed by -118bps to 6.54% in 2023, then plummeted by -373bps to 30.9% in 2024, then skyrocketed by 121bps to 6.63% in 2025.
  • Its last three reported values are 6.63% in Q3 2025, 33.44% for Q2 2025, and 6.22% during Q1 2025.